Banco Products Q4FY25 results: Income up 13.3% QoQ

Key numbers from Q4FY25

Banco Products (India) Ltd reported a higher top line for the quarter ended March 31, 2025 (Q4FY25), alongside a sharp quarter-on-quarter jump in profit. According to data cited from BSE and company announcements, total income for Q4FY25 stood at ₹730.31 crore. That was higher than ₹644.34 crore reported in the previous quarter (Q3FY25). On a year-on-year basis, total income rose versus ₹612.32 crore in Q4FY24.

Profitability also improved sharply sequentially. Profit Before Tax (PBT) was reported at ₹85.59 crore in Q4FY25, and Profit After Tax (PAT) came in at ₹68.16 crore. Earnings per share (EPS) for the quarter was stated at ₹9.50.

Revenue and expense movement: QoQ and YoY

The Q4FY25 dataset highlights a steady increase in operating scale compared to the immediately preceding quarter. Total income increased 13.3% quarter-on-quarter, from ₹644.34 crore in Q3FY25 to ₹730.31 crore in Q4FY25. On a year-on-year basis, the company posted 19.3% growth in total income compared with ₹612.32 crore in Q4FY24.

Expenses also moved up but at a slower pace than income on a sequential basis. Total expenses were reported at ₹644.72 crore for Q4FY25, up 6.5% QoQ from ₹605.40 crore in Q3FY25. Compared to Q4FY24, total expenses increased 19.8% from ₹538.23 crore.

The combination of faster sequential income growth and a more moderate sequential expense rise supported the quarter’s profit expansion.

Profit, tax, and EPS: what changed in Q4FY25

PBT for Q4FY25 was reported at ₹85.59 crore, which was up 119.8% from ₹38.94 crore in Q3FY25. On a year-on-year basis, PBT increased 15.5% from ₹74.09 crore in Q4FY24.

Tax expense for Q4FY25 was ₹17.43 crore. This was higher than ₹8.01 crore in Q3FY25, but lower than ₹23.06 crore in Q4FY24, as per the cited data.

PAT rose to ₹68.16 crore in Q4FY25, up 120.4% from ₹30.93 crore in Q3FY25. It was also higher than ₹51.03 crore in Q4FY24, representing 33.6% year-on-year growth.

EPS was reported at ₹9.50 for Q4FY25, up from ₹2.20 in Q3FY25 and ₹7.10 in Q4FY24.

Another view of quarterly performance (Dec 2024 to Dec 2025)

Separately, the provided quarterly result table (all figures in ₹ crore) shows net sales and profitability metrics across five quarters from Dec 2024 to Dec 2025. In that dataset, net sales rose from ₹257.04 crore in Dec 2024 to ₹308.30 crore in Mar 2025, before moderating to ₹300.96 crore in Dec 2025.

The same table shows that “Other Income” was volatile, including ₹101.98 crore in Mar 2025 and ₹108.92 crore in Sep 2025, versus ₹4.63 crore in Dec 2025. Profit After Tax (PAT) in this dataset was ₹137.33 crore in Mar 2025 and ₹137.77 crore in Sep 2025, compared with ₹31.29 crore in Dec 2025. Adjusted EPS moved in line with quarterly profitability, including ₹9.60 in Mar 2025 and ₹9.63 in Sep 2025.

Snapshot table: Q4FY25 financials (as reported)

Data source mentioned in the text: BSE and company announcements.

Quarterly results table: net sales to PAT (₹ crore)

Board process and disclosures to BSE

The company also informed BSE that a meeting of the Board of Directors was scheduled on 17/05/2025. The agenda included consideration and approval of standalone and consolidated audited financial results for the quarter and financial year ended 31st March, 2025, along with the auditors’ report.

The board meeting agenda also included a proposal to recommend a final dividend, if any, for FY25. In the annual report excerpt provided, the directors stated that they did not recommend any final dividend for FY25.

Dividend, bonus issue, and payout details mentioned

The annual report text included details of an interim dividend during FY25. The company declared and paid an interim dividend of 550%, equating to ₹11 per equity share of face value ₹2 each. The payout absorbed ₹157.34 crore (gross) for the year ended 31.03.2025, on expanded equity share capital after the issue and allotment of bonus shares.

The bonus shares were issued in a 1:1 ratio during the financial year, as stated. The same section compares the interim dividend with the prior year (FY24), when an interim dividend of 1000% or ₹20 per ₹2 equity share was paid.

FY25 operating indicators: ROE, cost mix, R&D, domestic and export sales

The provided text states that the company delivered ROE of 30.08% in the year ending March 31, 2025, compared with its five-year average ROE of 22.55%, based on consolidated financials.

The cost mix commentary notes that the company spent less than 1% of its operating revenues towards interest expenses and 10.43% towards employee cost in FY25.

The annual report excerpt also notes R&D spending at 0.61% of turnover. On the sales mix, domestic sales were stated at ₹764 crore in the period under review versus ₹727 crore in the previous year, a 5.09% increase. Export sales were stated at ₹323 crore versus ₹265 crore in the previous year, with overall sales mix at domestic 70.28% and exports 29.72%.

Market impact and why investors track these line items

For investors, the Q4FY25 data points underline two separate but related themes. First, the reported Q4FY25 sequential increase in total income (to ₹730.31 crore) alongside a sharper sequential rise in PAT (to ₹68.16 crore) highlights operating leverage in a quarter where expenses increased more slowly than income.

Second, the annual report items on dividend, the bonus issue (1:1), and the explicit statement that no final dividend was recommended for FY25 help set expectations around capital return policy. The cost structure indicators, including interest expense being under 1% of operating revenues and employee cost at 10.43% of operating revenues, also provide context on how sensitive earnings may be to financing costs and workforce-related expenses.

Conclusion

Banco Products (India) Ltd reported higher Q4FY25 total income of ₹730.31 crore with PAT of ₹68.16 crore and EPS of ₹9.50, supported by faster sequential income growth than expenses. The company’s filings also highlight the FY25 interim dividend of ₹11 per share, the 1:1 bonus issue during the year, and the board’s statement that no final dividend was recommended for FY25. Investors will continue to track subsequent company announcements and disclosures following the board process for audited standalone and consolidated financial results for FY25.